For example, the ERBB2/PIK3/AKT/mTOR pathway is known for its relevance in breast cancer, but recently a relevant actionable mutation from the same pathway, PIK3R1W624R was also identified in ovarian cancer [18]. Here, ERBB2 is linked to breast carcinoma.